Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABOUT YOU HOLDING AG | YOU | Oct 30, 2024 | 3.16 | -1.10 |
Absa Group Limited | AU61 | Oct 30, 2024 | 8.65 | -2.81 |
ABSOLICON SOLAR COLLEC. B | ZY0 | Oct 30, 2024 | 0.32 | 0.00 |
AC Immune SA | IMR | Oct 30, 2024 | 2.71 | -1.10 |
Acacia Research Corporation | AZG2 | Oct 30, 2024 | 4.30 | 0.00 |
AcadeMedia | V8T | Oct 30, 2024 | 5.56 | -0.54 |
Acadia Healthcare Company, Inc. | 7RA | Oct 30, 2024 | 47.40 | +0.42 |
ACADIA Pharmaceuticals Inc. | DR6 | Oct 30, 2024 | 13.54 | -0.04 |
Acadia Realty Trust | WX1 | Oct 30, 2024 | 22.40 | -0.89 |
Acadian Timber Corp | 779 | Oct 30, 2024 | 11.90 | 0.00 |
Acanthe Developpement SA | ADX | Oct 30, 2024 | 0.33 | +3.83 |
Acarix | 7AC | Oct 30, 2024 | 0.02 | -3.57 |
Acast AB | 0PN | Oct 30, 2024 | 1.30 | -0.38 |
Acasti Pharma A | A1P0 | Oct 30, 2024 | 2.78 | 0.00 |
Accelerate Diagnostics | 1A80 | Oct 30, 2024 | 1.61 | -1.83 |
ACCELLERON IND. ADR/1 | ZH20 | Oct 30, 2024 | 53.00 | 0.00 |
Accent Resources NL | A2R | Oct 30, 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Oct 30, 2024 | 0.02 | -4.55 |
Accentro Real Estate AG | A4Y | Oct 30, 2024 | 0.54 | +24.42 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Oct 30, 2024 | 320.70 | -3.94 |
Accesso Technology Group Plc | LQG | Oct 30, 2024 | 5.70 | -1.72 |
Acciona SA | AJ3 | Oct 30, 2024 | 120.00 | -2.76 |
Acco Brands Corporation | A3B | Oct 30, 2024 | 4.44 | -1.77 |
Accolade, Inc. | 4NE1 | Oct 30, 2024 | 3.02 | -2.58 |
Acconeer | 2LU | Oct 30, 2024 | 0.45 | -1.73 |
Accor | ACR1 | Oct 30, 2024 | 8.30 | +0.61 |
Accor SA | ACR | Oct 30, 2024 | 41.76 | -1.14 |
Accsys Technologies | 1D8 | Oct 30, 2024 | 0.56 | +1.26 |
Accuray Incorporated | XEJ | Oct 30, 2024 | 1.69 | -0.59 |
Ace Hardware Indonesia TBK | 4AH1 | Oct 30, 2024 | 0.04 | -4.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.